Print version of this report
TGA Action ID RC-2025-RN-00459-1
Type of Product Medical Device
Product Name/Description Urine Controls. An in vitro diagnostic medical device (IVD).

Liquid Urine Control – Level 2
Catalogue Number: UC5074
Batch/Lot: 1337UC
UDI: 05055273207569
Expiry Date: 28th Feb 2026

Assayed Urine Control – Level 3
Catalogue Number:
Batch/Lot: AU2353
UDI: 05055273200546
Expiry Date: 28th Aug 2028
ARTG Number 204567
Action Type Product Correction
Action Level Hospital
Hazard Classification Class II
Reason for the Action Randox can confirm there has been a transcription error in the Instructions for Use (IFU) for Liquid Urine Control Level 2, lot 1337UC, and Assayed Urine Control Level 3, lot 1358UC.

For Liquid Urine Control Level 2 lot 1337UC the targets and ranges for the analyte Creatinine, in units mmol/l, have been listed incorrectly in the ‘Method’, ‘Siemens Atellica Solution’ and ‘Siemens Dimension RxL/Max/Xpand/EXL’ sections on the IFU.

For Assayed Urine Control Level 3 lot 1358UC the targets and ranges for the analyte Creatinine, in units mmol/l, have been listed incorrectly in the ‘Method’ section on the IFU.
Instructions for Customers/Users Customers should be aware that Randox Laboratories has updated the targets and ranges for creatinine. The customer letter contains the updated targets and ranges.

The value sheets have been updated and are available on www.randox.com. Customers should discard the previous version and download the updated version.


This action has been closed out on 13/05/2026
Action Commencement Date 9/05/2025
Responsible Entity Randox Australia Pty Ltd
Contact Information 02 9615 4640 - Randox Australia Office